For the Inventor, By the Inventor

Enter inventor name

Roslindale, MA, United States of America

Andrew L Kung

USPTO Granted Patents = 9

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Roslindale, MA (US) (2006)
Walpole, MA (US) (2008 - 2019)

Company Filing History:

Dana-farber-cancer Institute Inc.

Washington University

where one patent can have more than one assignee

Years Active: 2006-2019

Loading Chart...

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10329626 - NOL3 is a predictor of patient outcome (2019-06-25),

2. 9533980 - NOL3 is a predictor of patient outcome (2017-01-03),

3. 8999661 - Compositions for detecting cell death and methods of use thereof (2015-04-07),

4. 8841067 - NOL3 is a predictor of patient outcome (2014-09-23),

5. 7892767 - Phosphospecific chemokine receptor antibodies (2011-02-22),

6. 7781393 - Methods for inhibiting tumor cell growth (2010-08-24),

7. 7732658 - Composition and method for imaging cells (2010-06-08),

8. 7399851 - Composition and method for imaging cells (2008-07-15),

9. 6986881 - Identification of compounds that modify transcriptional responses to hypoxia (2006-01-17),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…